Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics

J Thromb Thrombolysis. 1999 Aug;8(2):89-103. doi: 10.1023/a:1008954916972.

Authors

P J Goldschmidt-Clermont¹, C M Roos, G E Cooke

Affiliation

¹ Heart and Lung Institute, and Division of Cardiology, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio, USA. goldschmidt-1@medctr.osu.edu

PMID: 10436139
DOI: 10.1023/a:1008954916972

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antigens, Human Platelet / genetics*
Genetic Predisposition to Disease
Humans
Myocardial Infarction / etiology*
Platelet Aggregation Inhibitors / pharmacology*
Platelet Aggregation Inhibitors / therapeutic use*
Polymorphism, Genetic*
Risk Factors
Thromboembolism / complications*
Thromboembolism / genetics*

Substances

Antigens, Human Platelet
Platelet Aggregation Inhibitors
human platelet antigen 1b